Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/31/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Jan H.M. Schellens

Wrong Dr. Jan H.M. Schellens?

Head of the Department of Clinica...

Phone: +31 *********
Local Address: Amsterdam, Netherlands
The Netherlands Cancer Institute

Employment History

Board Memberships and Affiliations


  • MD
  • PhD
23 Total References
Web References
San Antonio Breast Cancer Symposium: Faculty - Faculty, 31 Jan 2015 [cached]
Jan H.M. Schellens, MD, PhD
Head, Department of Clinical Pharmacology
The Netherlands Cancer Institute
Dr. Schellens is a board certified medical oncologist and clinical pharmacologist with basic training in chemistry and teaches oncology and clinical pharmacology at Utrecht University, Netherlands.
He is head of the department of Clinical Pharmacology at the Netherlands Cancer Institute, involved in translational research and early clinical studies.
Dr. Schellens is a member of the Dutch Medicines Evaluation Board MEB, part of the EMA and Chairperson Scientific Advisory Group Oncology (SAG-Oncology to the EMA).
EACPT Historical Make up of Exec Comm Sept 2007 | European Association for Clinical Pharmacology and Therapeutics, 1 Sept 2007 [cached]
This congress was followed in 2007 by a very well attended (some 1000 delegates) congress organised in Amsterdam by Prof Jan Schellens and his colleagues.
Prof Jan Schellens
Prof Jan Schellens
Prof Jan Schellens ( on Committee 2007 - 2011 )
Prof Jan Schellens
9th Congress Edinburgh
Prof. Jan H.M. Schellens, ..., 5 Nov 2007 [cached]
Prof. Jan H.M. Schellens, The Netherlands
Translational research: 4 ways to fix clinical trials | Clinuity, 29 Sept 2011 [cached]
A similar union of four institutions is in the works in the Netherlands, says Jan Schellens, an oncologist and pharmacologist at the Netherlands Cancer Institute in Amsterdam.
About one-quarter of the molecules entering clinical trials fail because of "poor pharmacology", says Schellens. The drug may not be readily absorbed, for example, or may not reach its target organ. With a simple test in humans, he says, "you could kill that drug much earlier, before you have invested so much time and money".
Few, says Schellens, plan so far ahead.
Other People with the name "Schellens":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.